Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
37.6M
-
Number of holders
-
125
-
Total shares
-
36M
-
Shares change
-
-1.81M
-
Total reported value, excl. options
-
$134M
-
Value change
-
-$14.1M
-
Put/Call ratio
-
1.99
-
Number of buys
-
65
-
Number of sells
-
-67
-
Price
-
$3.72
Significant Holders of NEVRO CORP - Common Stock, par value $0.001 per share (NVRO) as of Q4 2024
164 filings reported holding NVRO - NEVRO CORP - Common Stock, par value $0.001 per share as of Q4 2024.
NEVRO CORP - Common Stock, par value $0.001 per share (NVRO) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36M shares
of 37.6M outstanding shares and own 95.68% of the company stock.
Largest 10 shareholders include ArrowMark Colorado Holdings LLC (4.36M shares), ARMISTICE CAPITAL, LLC (3.74M shares), BlackRock, Inc. (3.05M shares), VANGUARD GROUP INC (2.06M shares), D. E. Shaw & Co., Inc. (1.8M shares), BRAIDWELL LP (1.7M shares), Rock Springs Capital Management LP (1.65M shares), Shay Capital LLC (1.08M shares), MORGAN STANLEY (1.04M shares), and UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (932K shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.